Besufetamig
Product Specifications
CAS Number
3037124-22-1
Target
Integrin, PD-1/PD-L1
Related Pathways
Apoptosis, Cytoskeletal Signaling, Cell Cycle/Checkpoint, Immunology/Inflammation
Bioactivity
Besufetamig is a bispecific antibody targeting programmed cell death protein 1 (PD-1) and the CD3ε chain. It modulates immune cell activity, exerting both immunosuppressive and antitumor effects. Besufetamig holds promise for cancer research.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
